Cargando…

Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2

A recently published article described the safety, tolerability, and pharmacokinetic profile of molnupiravir (Painter et al. 2021), a novel antiviral agent with potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holman, Wendy, Holman, Wayne, McIntosh, Stacy, Painter, Wendy, Painter, George, Bush, Jim, Cohen, Oren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380870/ https://www.ncbi.nlm.nih.gov/pubmed/34425873 http://dx.doi.org/10.1186/s13063-021-05538-5

Ejemplares similares

Progress Toward a Large-Scale Synthesis of Molnupiravir (MK-4482, EIDD-2801) from Cytidine
por: Ahlqvist, Grace P., et al.
Publicado: (2021)

Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020)

Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020)

Short Synthesis of Molnupiravir (EIDD-2801) via a Thionated Uridine Intermediate
por: Dey, Raghunath, et al.
Publicado: (2021)

Evaluation of molnupiravir (EIDD-2801) efficacy against SARS-CoV-2 in the rhesus macaque model
por: Johnson, Dylan M., et al.
Publicado: (2023)

Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2021)

Correction: Conversion of N-acyl amidines to amidoximes: a convenient synthetic approach to molnupiravir (EIDD-2801) from ribose
por: Ahmed, Ajaz, et al.
Publicado: (2022)

SARS-CoV-2 Infection is Effectively Treated and Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2021)

Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19
por: Painter, George R, et al.
Publicado: (2021)

A High‐Yielding Synthesis of EIDD‐2801 from Uridine
por: Steiner, Alexander, et al.
Publicado: (2020)

Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2
por: Painter, Wendy P., et al.
Publicado: (2021)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Molnupiravir and Its Active Form, EIDD-1931, Show Potent Antiviral Activity against Enterovirus Infections In Vitro and In Vivo
por: Li, Yuexiang, et al.
Publicado: (2022)

Acute SARS-CoV-2 Infection is Highly Cytopathic, Elicits a Robust Innate Immune Response and is Efficiently Prevented by EIDD-2801
por: Wahl, Angela, et al.
Publicado: (2020)

Preparing anti-SARS-CoV-2 agent EIDD-2801 by a practical and scalable approach, and quick evaluation via machine learning
por: Qin, Zhen, et al.
Publicado: (2021)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2020)

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

A Computational Study on Thiourea Analogs as Potent MK-2 Inhibitors
por: Hao, Ming, et al.
Publicado: (2012)

Pharmacokinetics of ß-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: FitzGerald, Richard, et al.
Publicado: (2022)

Naturally occurring modified ribonucleosides
por: McCown, Phillip J., et al.
Publicado: (2020)

Metabolic labeling of RNA using multiple ribonucleoside analogs enables the simultaneous evaluation of RNA synthesis and degradation rates
por: Kawata, Kentaro, et al.
Publicado: (2020)

N-Ribosyltransferase From Archaeoglobus veneficus: A Novel Halotolerant and Thermostable Biocatalyst for the Synthesis of Purine Ribonucleoside Analogs
por: Acosta, Javier, et al.
Publicado: (2020)

Technical note - elliptic pick up C-2801-50-1
por: Oreberg, P E
Publicado: (1987)

Ribonucleosides for an Artificially Expanded Genetic Information System
por: Kim, Hyo-Joong, et al.
Publicado: (2014)

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors
por: Langendries, Lana, et al.
Publicado: (2021)

Abiotic synthesis of purine and pyrimidine ribonucleosides in aqueous microdroplets
por: Nam, Inho, et al.
Publicado: (2018)

Cobalt-assisted route to rare carbocyclic C-ribonucleosides
por: Ojeda-Porras, A. C., et al.
Publicado: (2023)

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study
por: Khoo, Saye H, et al.
Publicado: (2021)

miR-4482 and miR-3912 aim for 3ʹUTR of ERG mRNA in prostate cancer
por: Mumtaz, Sidra, et al.
Publicado: (2023)

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
por: Reynard, Olivier, et al.
Publicado: (2015)

Abiotic production of sugar phosphates and uridine ribonucleoside in aqueous microdroplets
por: Nam, Inho, et al.
Publicado: (2017)

Metabolic turnover and dynamics of modified ribonucleosides by (13)C labeling
por: Gameiro, Paulo A., et al.
Publicado: (2021)

Photoactivatable ribonucleosides mark base-specific RNA-binding sites
por: Bae, Jong Woo, et al.
Publicado: (2021)

Ribonucleoside Hydrolases–Structure, Functions, Physiological Role and Practical Uses
por: Shaposhnikov, Leonid A., et al.
Publicado: (2023)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Comparing molnupiravir and nirmatrelvir/ritonavir efficacy and the effects on SARS-CoV-2 transmission in animal models
por: Cox, Robert M., et al.
Publicado: (2023)

Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer
por: Yellapu, Nanda Kumar, et al.
Publicado: (2022)

Position-dependent effects of regioisomeric methylated adenine and guanine ribonucleosides on translation
por: You, Changjun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u0d7be0r4nqsbbpcblq1ldtehq